CD19 and B-cell chronic lymphocytic leukemia: Secondly, CD3+ T, CD19+ B, and CD19+CD5+ cells of CD19+CD5+ZAP+ and CD19+CD5+ZAP- CLL patients were evaluated for their intracellular IL-4 and IFN-γ contents.